相关实验视频

Updated: Sep 12, 2025

Author Spotlight: The Significance of Isolation, Culture, and Adipogenic Induction of SVF-Derived Preadipocytes from Mouse Perivascular Adipose Tissue

Author Spotlight: The Significance of Isolation, Culture, and Adipogenic Induction of SVF-Derived Preadipocytes from Mouse Perivascular Adipose Tissue

Published on: July 21, 2023

炎症相关的心上腺脂肪组织的最新进展,用于心房患者

Jiawei Li^1,2,3,4, Maomao Zhao^1,2,3,4, Lu Bai^1,2,3,4

¹Department of Cardiology, First Hospital of Lanzhou University, 730000 Lanzhou, Gansu, China.

Reviews in cardiovascular medicine

|August 8, 2025

概括

与心房 (AF) 相关的炎症涉及心上脂肪组织 (EAT). EAT释放炎症性细胞因子,促进纤维化和增加AF风险,突出其作为生物标志物和治疗点的潜力.

科学领域:

心脏病学心脏病学
炎症研究炎症研究
生物标志物发现发现

背景情况:

炎症和心房动 (AF) 之间的联系是一个日益增长的研究领域.
心脂肪组织 (EAT) 通过炎症,代谢和电生理路径在AF病变发生中发挥作用.
EAT影响AF的结果,可能是其发展的关键因素.

研究的目的:

探索AF中EAT与炎症相关的机制.
评估EAT作为AF风险生物标志物的临床潜力.
评估EAT作为AF的潜在治疗点.

主要方法:

审查关于EAT和AF的现有文献.
分析EAT释放的炎症媒介,如IL-1β和TNF-α.
检查EAT对心肌细胞亡,纤维化和电生理学稳定的影响.

主要成果:

EAT释放的促炎性细胞因子 (IL-1β,TNF-α) 诱导心肌细胞亡和纤维化.
增加EAT厚度和体积被确定为AF风险的关键生物标志物.
这些变化损害了心脏的电生理稳定性,增加了心律失常风险.

结论:

通过炎症机制,EAT与AF病原发生有显著的关联.
EAT作为AF风险的关键生物标志物,提供诊断和治疗见解.
需要进一步的研究才能充分理解EAT在AF中的作用和治疗潜力.

关键词:

心房动 (AF) 是一种心房动.生物标志物生物标志物表心脂肪组织 (EAT)这是一种炎症炎症炎症炎症.

更多相关视频

The Isolation and Culture of Primary Epicardial Cells Derived from Human Adult and Fetal Heart Specimens

The Isolation and Culture of Primary Epicardial Cells Derived from Human Adult and Fetal Heart Specimens

Published on: April 24, 2018

Innovative Adipose Tissue Fractionation for Transforming Fat into Specialized Components

Innovative Adipose Tissue Fractionation for Transforming Fat into Specialized Components

Published on: July 11, 2025

相关概念视频

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Inflammation

Inflammation